• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种疫苗对感染 SARS-CoV-2 伽马谱系患者的宿主内遗传多样性的影响。

Impact of Vaccination on Intra-Host Genetic Diversity of Patients Infected with SARS-CoV-2 Gamma Lineage.

机构信息

Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.

Vigilância Epidemiológica, Secretaria de Saúde de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.

出版信息

Viruses. 2024 Sep 26;16(10):1524. doi: 10.3390/v16101524.

DOI:10.3390/v16101524
PMID:39459859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512383/
Abstract

The high transmissibility, rapid evolution, and immune escape of SARS-CoV-2 variants can influence the course of infection and, in turn, morbidity and mortality in COVID-19, posing a challenge in controlling transmission rates and contributing to the emergence and spread of new variants. Understanding the factors that shape viral genetic variation is essential for comprehending the evolution and transmission of SARS-CoV-2, especially in vaccinated individuals where immune response plays a role in the progression and spread of this disease. In this context, we evaluated the impact of immunity induced by the CoronaVac vaccine (Butantan/Sinovac) on intra-host genetic diversity, analyzing 118 whole-genome sequences of SARS-CoV-2 from unvaccinated and vaccinated patients infected with the Gamma variant. Vaccination with CoronaVac favors negative selection at the intra-host level in different genomic regions. It prevents greater genetic diversity of SARS-CoV-2, reinforcing the importance of vaccination in reducing the emergence of new mutations and virus transmission.

摘要

SARS-CoV-2 变体的高传染性、快速进化和免疫逃逸能力会影响感染过程,进而影响 COVID-19 的发病率和死亡率,这给控制传播率带来了挑战,并导致新变体的出现和传播。了解影响病毒遗传变异的因素对于理解 SARS-CoV-2 的进化和传播至关重要,特别是在接种疫苗的个体中,免疫反应在该疾病的进展和传播中起着作用。在这种情况下,我们评估了科兴疫苗(巴西布坦坦研究所/北京科兴中维)诱导的免疫对宿主内遗传多样性的影响,分析了来自未接种和接种疫苗的感染伽马变异株患者的 118 株 SARS-CoV-2 全基因组序列。科兴疫苗接种有利于在不同基因组区域对宿主内水平的负选择。它可以防止 SARS-CoV-2 的遗传多样性增加,从而强调了接种疫苗在减少新突变和病毒传播方面的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c6/11512383/0267bf17d5f1/viruses-16-01524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c6/11512383/1efba4ddb604/viruses-16-01524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c6/11512383/0267bf17d5f1/viruses-16-01524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c6/11512383/1efba4ddb604/viruses-16-01524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c6/11512383/0267bf17d5f1/viruses-16-01524-g002.jpg

相似文献

1
Impact of Vaccination on Intra-Host Genetic Diversity of Patients Infected with SARS-CoV-2 Gamma Lineage.接种疫苗对感染 SARS-CoV-2 伽马谱系患者的宿主内遗传多样性的影响。
Viruses. 2024 Sep 26;16(10):1524. doi: 10.3390/v16101524.
2
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.肯尼亚人群中接种疫苗和未接种疫苗患者体内 SARS-CoV-2 宿主内基因进化特征分析
J Virol. 2025 Jun 17;99(6):e0048225. doi: 10.1128/jvi.00482-25. Epub 2025 May 6.
3
Impact of vaccination on SARS-CoV-2 evolution and immune escape variants.疫苗接种对 SARS-CoV-2 进化和免疫逃逸变异株的影响。
Vaccine. 2024 Aug 30;42(21):126153. doi: 10.1016/j.vaccine.2024.07.054. Epub 2024 Jul 26.
4
SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India.严重急性呼吸综合征冠状病毒2的“炼金术”:了解印度严重急性呼吸综合征冠状病毒2进化过程中年龄、疫苗接种和地理因素的动态变化
PLoS Negl Trop Dis. 2025 Mar 10;19(3):e0012918. doi: 10.1371/journal.pntd.0012918. eCollection 2025 Mar.
5
Quantifying the impact of vaccination on transmission and diversity of influenza A variants in pigs.量化疫苗接种对猪甲型流感病毒变种传播和多样性的影响。
J Virol. 2024 Dec 17;98(12):e0124524. doi: 10.1128/jvi.01245-24. Epub 2024 Nov 12.
6
Nanopore sequencing reveals the genomic diversity of the variants of concern of SARS-CoV-2 during 2021 disease outbreak in Pakistan.纳米孔测序揭示了2021年巴基斯坦疾病爆发期间新冠病毒变异株的基因组多样性。
Sci Rep. 2025 Aug 1;15(1):28129. doi: 10.1038/s41598-025-12774-1.
7
Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history.具有不同疫苗接种史的小鼠中,单价和多价亚单位疫苗针对新冠病毒变异株的免疫原性。
Microbiol Spectr. 2025 Jul 17:e0290724. doi: 10.1128/spectrum.02907-24.
8
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.针对 COVID-19 的一种改良信使核糖核酸-脂质纳米颗粒候选疫苗的安全性和免疫原性:一项 1 期、剂量递增研究的结果。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2408863. doi: 10.1080/21645515.2024.2408863. Epub 2024 Oct 18.
9
Dynamic monitoring of antibody titers in people living with HIV during Omicron epidemic: comparison between unvaccinated and vaccinated individuals.奥密克戎疫情期间HIV感染者抗体滴度的动态监测:未接种疫苗者与接种疫苗者的比较
BMC Infect Dis. 2025 Jul 30;25(1):962. doi: 10.1186/s12879-025-11387-3.
10
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.COVID-19 住院患者中 SARS-CoV-2 感染的持续性及病毒的体内和种间进化。
J Med Virol. 2024 Jun;96(6):e29708. doi: 10.1002/jmv.29708.

本文引用的文献

1
Impact of vaccination on SARS-CoV-2 evolution and immune escape variants.疫苗接种对 SARS-CoV-2 进化和免疫逃逸变异株的影响。
Vaccine. 2024 Aug 30;42(21):126153. doi: 10.1016/j.vaccine.2024.07.054. Epub 2024 Jul 26.
2
Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的阿尔法、贝塔、德尔塔和奥密克戎变异株的疫苗诱导中和抗体的比较分析
Vaccines (Basel). 2024 May 9;12(5):515. doi: 10.3390/vaccines12050515.
3
Insights into the SARS-CoV-2 ORF6 Mechanism of Action.
深入了解 SARS-CoV-2 ORF6 的作用机制。
Int J Mol Sci. 2023 Jul 18;24(14):11589. doi: 10.3390/ijms241411589.
4
The Mutational Landscape of SARS-CoV-2.SARS-CoV-2 的突变景观。
Int J Mol Sci. 2023 May 22;24(10):9072. doi: 10.3390/ijms24109072.
5
The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target.SARS-CoV-2 的包膜(E)蛋白作为药物作用靶点。
Viruses. 2023 Apr 19;15(4):1000. doi: 10.3390/v15041000.
6
Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals.未接种疫苗和接种疫苗个体中 SARS-CoV-2 谱系的宿主内遗传多样性。
Nat Commun. 2023 Mar 31;14(1):1793. doi: 10.1038/s41467-023-37468-y.
7
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations.奥密克戎变异株感染患者和疫苗接种者的免疫反应:同源和异源接种后的比较。
Commun Biol. 2022 Sep 2;5(1):903. doi: 10.1038/s42003-022-03849-0.
8
Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil.巴西 SARS-CoV-2 疫情的基因组流行病学。
Nat Microbiol. 2022 Sep;7(9):1490-1500. doi: 10.1038/s41564-022-01191-z. Epub 2022 Aug 18.
9
Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)伽马谱系毒株的引入及2019冠状病毒病(COVID-19)疫苗接种对巴西一座城市流行病学态势的影响
Commun Med (Lond). 2022 Apr 13;2:41. doi: 10.1038/s43856-022-00108-5. eCollection 2022.
10
Mutations and Evolution of the SARS-CoV-2 Spike Protein.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的突变与进化
Viruses. 2022 Mar 19;14(3):640. doi: 10.3390/v14030640.